| pubmed-article:7527456 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7527456 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7527456 | lifeskim:mentions | umls-concept:C1516238 | lld:lifeskim |
| pubmed-article:7527456 | lifeskim:mentions | umls-concept:C0280100 | lld:lifeskim |
| pubmed-article:7527456 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:7527456 | lifeskim:mentions | umls-concept:C0146224 | lld:lifeskim |
| pubmed-article:7527456 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:7527456 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:7527456 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:7527456 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:7527456 | pubmed:dateCreated | 1995-1-12 | lld:pubmed |
| pubmed-article:7527456 | pubmed:abstractText | The objectives of this phase I trial were to determine the dose-limiting toxicities (DLTs) of the novel topoisomerase I inhibitor topotecan combined with cisplatin, to define the maximum-tolerated doses (MTDs) of the combination without and with the use of filgrastim, and to define recommended doses for phase II trials. | lld:pubmed |
| pubmed-article:7527456 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7527456 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7527456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7527456 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7527456 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:7527456 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:7527456 | pubmed:author | pubmed-author:MillerA AAA | lld:pubmed |
| pubmed-article:7527456 | pubmed:author | pubmed-author:SchilskyR LRL | lld:pubmed |
| pubmed-article:7527456 | pubmed:author | pubmed-author:RosnerG LGL | lld:pubmed |
| pubmed-article:7527456 | pubmed:author | pubmed-author:HargisJ BJB | lld:pubmed |
| pubmed-article:7527456 | pubmed:author | pubmed-author:FieldsS ZSZ | lld:pubmed |
| pubmed-article:7527456 | pubmed:author | pubmed-author:LilenbaumR... | lld:pubmed |
| pubmed-article:7527456 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7527456 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:7527456 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7527456 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7527456 | pubmed:pagination | 2743-50 | lld:pubmed |
| pubmed-article:7527456 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:meshHeading | pubmed-meshheading:7527456-... | lld:pubmed |
| pubmed-article:7527456 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7527456 | pubmed:articleTitle | Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study. | lld:pubmed |
| pubmed-article:7527456 | pubmed:affiliation | University of Tennessee, Memphis 38163. | lld:pubmed |
| pubmed-article:7527456 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7527456 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7527456 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7527456 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7527456 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7527456 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7527456 | lld:pubmed |
